398
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Maternal and Fetal Risk Factors for Neonatal Hypoxic-Ischemic Encephalopathy: A Retrospective Study

ORCID Icon, &
Pages 537-545 | Received 20 Oct 2022, Accepted 03 Feb 2023, Published online: 13 Feb 2023

References

  • Bonifacio SL, Hutson S. The term newborn: evaluation for hypoxic-ischemic encephalopathy. Clin Perinatol. 2021;48(3):681–695. doi:10.1016/j.clp.2021.05.014
  • Greco P, Nencini G, Piva I, et al. Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020;120(2):277–288. doi:10.1007/s13760-020-01308-3
  • Victor S, Rocha-Ferreira E, Rahim A, Hagberg H, Edwards D. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022;181(3):875–887. doi:10.1007/s00431-021-04320-8
  • Wang Z, Zhang P, Zhou W, et al. Neonatal hypoxic-ischemic encephalopathy diagnosis and treatment: a National Survey in China. BMC Pediatr. 2021;21(1):261. doi:10.1186/s12887-021-02737-6
  • Thompson CM, Puterman AS, Linley LL, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997;86(7):757–761. doi:10.1111/j.1651-2227.1997.tb08581.x
  • Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33(10):696–705. doi:10.1001/archneur.1976.00500100030012
  • Ayrapetyan M, Talekar K, Schwabenbauer K, et al. Apgar scores at 10 minutes and outcomes in term and late preterm neonates with hypoxic-ischemic encephalopathy in the cooling era. Am J Perinatol. 2019;36(5):545–554. doi:10.1055/s-0038-1670637
  • Michniewicz B, Al Saad SR, Karbowski LM, Gadzinowski J, Szymankiewicz M, Szpecht D. Organ complications of infants with hypoxic ischemic encephalopathy before therapeutic hypothermia. Ther Hypothermia Temp Manag. 2021;11(1):58–63. doi:10.1089/ther.2020.0035
  • Pouppirt NR, Martin V, Pagnotto-Hammitt L, Spittle AJ, Flibotte J, DeMauro SB. The general movements assessment in neonates with hypoxic ischemic encephalopathy. J Child Neurol. 2021;36(8):601–609. doi:10.1177/0883073820981515
  • Torres AR, Naranjo JD, Salvador C, Mora M, Papazian O. Predominant factors of neonatal encephalopathy: hypoxic and ischemia, a global problem. Medicina. 2019;79(Suppl 3):15–19.
  • Rossi AC, Prefumo F. Antepartum and intrapartum risk factors for neonatal hypoxic-ischemic encephalopathy: a systematic review with meta-analysis. Curr Opin Obstet Gynecol. 2019;31(6):410–417. doi:10.1097/GCO.0000000000000581
  • Fox A, Doyle E, Geary M, Hayes B. Placental pathology and neonatal encephalopathy. Int J Gynaecol Obstet. 2023;160(1):22–27. doi:10.1002/ijgo.14301
  • Peebles PJ, Duello TM, Eickhoff JC, McAdams RM. Antenatal and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy. J Perinatol. 2020;40(1):63–69. doi:10.1038/s41372-019-0531-6
  • Wang J, Tao E, Mo M, et al. Perinatal risk factors influencing neonatal hypoxic ischemic encephalopathy in Southern China: a case-control study. Am J Perinatol. 2021;38(S 01):e182–e186. doi:10.1055/s-0040-1708884
  • Group of Neonatology; Chinese Pediatric Society; Chinese Medical Association. Diagnostic criteria for neonatal hypoxic-ischemic encephalopathy. Chin J Pediatr. 2005;43(8):584.
  • Wang X. Guideline of evidence-based treatment for hypoxic-ischemic encephalopathy in full-term infants(standard version, 2011). Chin J Evidence-Based Pediatr. 2011;1:548.
  • Pálsdóttir K, Thórkelsson T, Hardardóttir H, Dagbjartsson A. Birth asphyxia, neonatal risk factors for hypoxic ischemic encephalopathy. Laeknabladid. 2007;93(10):669–673.
  • Ali A, Yalçın R, Ünlüer-Gümüştaş A. Cranial MR characteristics of Cerebral Palsy cases and correlation of findings with clinical results. Turk J Pediatr. 2019;61(4):525–537. doi:10.24953/turkjped.2019.04.009
  • Wang Y, Luo S, Wang K, Hou Y, Yan H, Zhang Y. Maternal and neonatal exposure to risk factors for neonates with moderate or severe hypoxic ischemic encephalopathy: a cross-sectional study. Ital J Pediatr. 2022;48(1):188. doi:10.1186/s13052-022-01380-w
  • Liljestrom L, Wikstrom AK, Agren J, Jonsson M. Antepartum risk factors for moderate to severe neonatal hypoxic ischemic encephalopathy: a Swedish national cohort study. Acta Obstet Gynecol Scand. 2018;97(5):615–623. doi:10.1111/aogs.13316
  • Mooney C, O’Boyle D, Finder M, et al. Predictive modelling of hypoxic ischaemic encephalopathy risk following perinatal asphyxia. Heliyon. 2021;7(7):e07411. doi:10.1016/j.heliyon.2021.e07411
  • Torbenson VE, Tolcher MC, Nesbitt KM, et al. Intrapartum factors associated with neonatal hypoxic ischemic encephalopathy: a case-controlled study. BMC Pregnancy Childbirth. 2017;17(1):415. doi:10.1186/s12884-017-1610-3
  • Nadeem G, Rehman A, Bashir H. Risk Factors Associated With Birth Asphyxia in Term Newborns at a Tertiary Care Hospital of Multan, Pakistan. Cureus. 2021;13(10):e18759. doi:10.7759/cureus.18759
  • Khorram B, Kilmartin KC, Dahan M, et al. Outcomes of Neonates with a 10-min Apgar Score of Zero: a Systematic Review and Meta-Analysis. Neonatology. 2022;119(6):669–685. doi:10.1159/000525926
  • Michel A. Review of the Reliability and Validity of the Apgar Score. Adv Neonatal Care. 2022;22(1):28–34. doi:10.1097/ANC.0000000000000859
  • Hayes BC, McGarvey C, Mulvany S, et al. A case-control study of hypoxic-ischemic encephalopathy in newborn infants at >36 weeks gestation. Am J Obstet Gynecol. 2013;209(1):29.e21–29.e19. doi:10.1016/j.ajog.2013.03.023
  • Negro S, Benders M. Early Prediction of Hypoxic-Ischemic Brain Injury by a New Panel of Biomarkers in a Population of Term Newborns. Oxid Med Cell Longev. 2018;2018:7608108. doi:10.1155/2018/7608108
  • Murden S, Borbélyová V, Laštůvka Z, Mysliveček J, Otáhal J, Riljak V. Gender differences involved in the pathophysiology of the perinatal hypoxic-ischemic damage. Physiol Res. 2019;68(Suppl 3):S207–s217. doi:10.33549/physiolres.934356
  • Lundgren C, Brudin L, Wanby AS, Blomberg M. Ante- and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy. J Matern Fetal Neonatal Med. 2018;31(12):1595–1601. doi:10.1080/14767058.2017.1321628
  • Martinez-Biarge M, Diez-Sebastian J, Wusthoff CJ, Mercuri E, Cowan FM. Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy. Pediatrics. 2013;132(4):e952–959. doi:10.1542/peds.2013-0511
  • Yang W, Wang L. Maternal hypertensive disorders in pregnancy and risk of hypoxic-ischemia encephalopathy. J Matern Fetal Neonatal Med. 2021;34(11):1754–1762. doi:10.1080/14767058.2019.1647529
  • Parker SJ, Kuzniewicz M, Niki H, Wu YW. Antenatal and intrapartum risk factors for hypoxic-ischemic encephalopathy in a US birth cohort. J Pediatr. 2018;203:163–169. doi:10.1016/j.jpeds.2018.08.028
  • Chen HM, Gao LX, Wang JJ, Gao C. The correlation between AGT gene polymorphism and neonatal hypoxic-ischemic encephalopathy (HIE). Eur Rev Med Pharmacol Sci. 2019;23(5):2194–2199. doi:10.26355/eurrev_201903_17266
  • Xue LL, Wang F, Xiong LL, et al. A single-nucleotide polymorphism induced alternative splicing in Tacr3 involves in hypoxic-ischemic brain damage. Brain Res Bull. 2020;154:106–115. doi:10.1016/j.brainresbull.2019.11.001
  • Esih K, Goričar K, Rener-Primec Z, Dolžan V, Soltirovska-šalamon A. CARD8 and IL1B polymorphisms influence mri brain patterns in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Antioxidants. 2021;10(1):96. doi:10.3390/antiox10010096
  • Esih K, Goričar K. Genetic polymorphisms, gene-gene interactions and neurologic sequelae at two years follow-up in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Antioxidants. 2021;10(9):1495. doi:10.3390/antiox10091495
  • Kuzmanić Šamija R, Primorac D, Rešić B, et al. Association of NOS3 gene variants and clinical contributors of hypoxic-ischemic encephalopathy. Braz J Med Biol Res. 2014;47(10):869–875. doi:10.1590/1414-431x20143938
  • Wu Y, Zhu Z. The association between NOS3 gene polymorphisms and hypoxic-ischemic encephalopathy susceptibility and symptoms in Chinese Han population. Biomed Res Int. 2016;2016:1957374. doi:10.1155/2016/1957374
  • Sun L, Xia L, Wang M, et al. Variants of the OLIG2 gene are associated with cerebral palsy in Chinese Han infants with hypoxic-ischemic encephalopathy. Neuromolecular Med. 2019;21(1):75–84. doi:10.1007/s12017-018-8510-1
  • Kukec E, Goričar K, Dolžan V, Rener-Primec Z. HIF1A polymorphisms do not modify the risk of epilepsy nor cerebral palsy after neonatal hypoxic-ischemic encephalopathy. Brain Res. 2021;1757:147281. doi:10.1016/j.brainres.2021.147281
  • Li B, Dasgupta C, Huang L, Meng X, Zhang L. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy. Cell Mol Immunol. 2020;17(9):976–991. doi:10.1038/s41423-019-0257-6
  • Wang W, Jia L. Regulatory mechanism of MicroRNA-30b on neonatal hypoxic-ischemic encephalopathy (HIE). J Stroke Cerebrovasc Dis. 2021;30(3):105553. doi:10.1016/j.jstrokecerebrovasdis.2020.105553
  • Chen R, Wang M, Fu S, Cao F, Duan P, Lu J. MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN. Exp Ther Med. 2019;18(5):3299–3306. doi:10.3892/etm.2019.7936
  • Chen Z, Hu Y, Lu R, Ge M, Zhang L. MicroRNA-374a-5p inhibits neuroinflammation in neonatal hypoxic-ischemic encephalopathy via regulating NLRP3 inflammasome targeted Smad6. Life Sci. 2020;252:117664. doi:10.1016/j.lfs.2020.117664
  • Fei S, Cao L, Li S. microRNA-139-5p alleviates neurological deficit in hypoxic-ischemic brain damage via HDAC4 depletion and BCL-2 activation. Brain Res Bull. 2021;169:73–80. doi:10.1016/j.brainresbull.2020.12.020
  • Jia Y, Liu J, Hu H, Duan Q, Chen J, Li L. MiR-363-3p attenuates neonatal hypoxic-ischemia encephalopathy by targeting DUSP5. Neurosci Res. 2021;171:103–113. doi:10.1016/j.neures.2021.03.003